Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tenofovir alafenamide vs entecavir vs combination in high viral load chronic hepatitis B
ChiCTR2000039239Phase 4Recruiting
- Sponsor
- The Third Affiliated Hospital of Sun Yat-sen University
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir alafenamide and entecavir in Chronic Hepatitis B (CHB) (3 arms), sponsored by The Third Affiliated Hospital of Sun Yat-sen University. Primary endpoints: HBV DNA quantification at week 96, Alanine aminotransferase (ALT) at week 96 and 6 more. Started Nov 2020; status: recruiting.
02
Drugs
tenofovir alafenamideentecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR2000039239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039239.